Lincoln Pharma Share Price

Lincoln Pharma Share Price

NSE: LINCOLN
|
Pharmaceuticals
|
S Cap
₹ 632.00
+₹11.20 (1.80%)
1D
Last updated 07 Sep, 2026, 14:12 IST

Lincoln Pharma Share Price Today

As of 7 Sep 2026, Lincoln Pharma share price is ₹632.00. The stock opened at ₹626.80, compared to its previous close of ₹620.80. During today's trading session, Lincoln Pharma share price moved in the range of ₹617.70 to ₹640.00, with an average price of ₹628.85 for the day. Looking at its last 52-week, the stock has touched a low of ₹440.00 and a high of ₹770.00. On the performance front, Lincoln Pharma share price has increased by 0.37% over the last six months and is up 12.87% on a year-on-year basis.

₹617.70
1.80% up today
₹640.00
1D LOW
1D HIGH

Lincoln Pharma Returns Calculator

Circuit
L
H
₹496.65
₹744.95
52-week
L
H
₹440.00
₹770.00

About Lincoln Pharma

Lincoln Pharma Share Price
ISIN
INE405C01035
Sector Market Cap
₹ 1,239.34 Cr

Lincoln Pharmaceuticals Limited is engaged in the business of manufacturing and trading pharmaceutical products, as well as undertaking contract manufacturing from pharmaceuticals companies across India and the globe. The Company’s product categories include tablets, capsules, liquid injection, cream in tubes, eye/ear drops, dry power injection, SVP injectables, dry-powder suspensions, liquid injection, and pharma products. It offers products for anti-infective, respiratory system, gynecology, cardio and CNS (central nervous system), antibacterial, dermatological infection, anti-diabetic, and anti-malaria. The Company is also engaged in building a portfolio of lifestyle and chronic segments, primarily in women’s healthcare and dermatology. The Company caters to approximately 60 countries in Europe, Latin America, Africa, Asia Pacific, Southeast Asia, and 26 states across India. The Company has two manufacturing facilities located in Mehsana and Khatraj, Gujarat.

Lincoln Pharma Financial Highlights

  • Revenue: Lincoln Pharma reported revenue of ₹704.48 crore in FY26 vs ₹645.71 crore in FY25. It showed an increase of 9.10% on a yearly basis.
  • Operating Profit: Lincoln Pharma reported an operating profit of ₹115.63 crore in FY26 vs ₹109.19 crore in FY25. It showed an increase of 5.90% on a year-on-year basis.
  • Net Profit: Lincoln Pharma reported a net profit of ₹87.89 crore in FY26 vs ₹82.35 crore in FY25. It showed an increase of 6.73% on a yearly basis.

Lincoln Pharma Quarterly Result Highlights

  • Lincoln Pharma reported revenue of ₹201.54 crore in Jun 2026, compared with ₹183.08 crore in Mar 2026, representing an increase of 10.08% on a quarter-on-quarter (QoQ) basis.
  • Lincoln Pharma reported an operating profit of ₹47.55 crore in Jun 2026, compared with ₹16.70 crore in Mar 2026, representing an increase of 184.73% on a quarter-on-quarter (QoQ) basis.
  • Lincoln Pharma reported a profit of ₹36.23 crore in Jun 2026, compared with ₹11.63 crore in Mar 2026, reflecting an increase of 211.52% on a QoQ basis.
  • The earnings per share (EPS) of Lincoln Pharma stood at ₹41.11 during Jun 2026.

Data Source: BSE, Company announcements

Securities shown are illustrative, not recommendations. Past performance does not guarantee future results.

Know more
Promoters
49.78%
FII
4.60%
Other DII
0.27%
Retail and other
45.36%
Mutual funds
0.00%
Foreign Institutional Investor (FII)
FII shareholding by period
Sep 20254.72%
Dec 20254.70%
Mar 20265.19%
Jun 20264.60%
Mkt Cap Cr
1,239.34
P/E
12.85
P/B
1.64
ROE
11.60%
D/E
0.01
ROCE
15.18%
Div. Yield
0.29%
EPS(TTM)
43.88
Turnover
0.78
EV/EBITDA
8.45
Net Margin
0.00%
Op. Margin
0.00%
ROA
10.83%
Quick Ratio
0.00
Curr. Ratio
5.47
Based on fundamentals, this stock's
Step 5 of 5
Performance
Excellent
Lincoln Pharma. outperforming all market indices
Step 1 of 5
Valuation
Overvalued
Lincoln Pharma. appears overvalued compared to its peers
Step 5 of 5
Earnings
Excellent
Lincoln Pharma. revenue, operating profit and net profit are growing
Peer Comparison
Peer comparison — key ratios
NameMkt Cap CrP/EP/BROED/EROCEBook ValueDiv. YieldTurnoverEPS(TTM)
Sun Pharmaceutical Industries4,55,634.0037.605.4513.74%0.6117.33%93.240.84%0.4810.90
Divis Laboratories2,41,576.0082.5914.4115.32%0.0019.56%629.490.33%0.5598.19
Torrent Pharmaceuticals1,84,478.0085.5721.9425.49%1.6913.85%222.760.70%0.4958.70
Cipla1,11,888.0033.343.2511.27%0.0014.95%423.360.94%0.4543.52
Zydus Lifesciences1,11,820.0024.354.1218.59%0.3117.35%237.300.09%0.3335.38
Laurus Labs99,417.5091.1818.7616.77%0.4016.14%97.200.11%0.6713.72
Lupin96,528.8017.394.3023.76%0.0424.88%659.000.85%0.57129.18
Dr. Reddy's Laboratories96,322.1030.262.5311.07%0.1812.54%377.950.69%0.4138.68
Mankind Pharma96,179.6046.525.9011.74%0.3413.13%396.980.04%0.4449.37
Aurobindo Pharma95,127.2025.642.519.25%0.1911.76%394.820.24%0.3841.58

Auto-generated based on historical fundamentals; not a recommendation to buy/sell.

Lincoln Pharma Financials

Full statement

Income Statement · Consolidated

Income Statement · Consolidated — all values in INR Crore
ParticularsMar 2025Mar 2024Mar 2023Mar 2022
Revenue₹623.23₹580.55₹510.31₹472.12
Other Income₹22.48₹34.42₹22.47₹10.00
Total Revenue₹645.71₹614.97₹532.78₹482.12
Total Expenses₹536.52₹492.73₹432.30₹386.18
Profit Before Tax₹109.19₹122.24₹100.48₹95.94
Tax₹26.84₹28.94₹27.58₹26.58
Profit After Tax₹82.35₹93.30₹72.90₹69.36
EPS - Basic₹41.11₹46.58₹36.40₹34.63
EPS - Diluted₹41.11₹46.58₹36.40₹34.63

Cash Flow · Consolidated

Cash Flow · Consolidated — all values in INR Crore
ParticularsMar 2025Mar 2024Mar 2023Mar 2022
Profit before tax₹109.19₹122.24₹100.48₹95.94
Income before WC changes₹110.15₹105.48₹100.25₹97.42
Change in Assets-₹12.20-₹37.43-₹13.13-₹10.97
Change in Liabilities₹21.37₹21.32-₹18.25₹13.38
Change in WC₹9.17-₹16.12-₹31.37₹2.40
Cash flow from Operations₹93.02₹63.22₹39.26₹76.13
Cash flow from Investing-₹78.95-₹57.34-₹36.64-₹78.08
Cash flow from Financing-₹6.40-₹5.18-₹4.50-₹2.56
Total Cash Flow₹7.67₹0.70-₹1.88-₹4.50
Cash (Start of the year)₹5.75₹5.05₹6.93₹11.44
Cash (End of the year)₹13.41₹5.75₹5.05₹6.93

Balance Sheet · Consolidated

Balance Sheet · Consolidated — all values in INR Crore
ParticularsMar 2025Mar 2024Mar 2023Mar 2022
Non-Current Assets₹297.07₹253.55₹220.21₹181.51
Current Assets₹499.94₹446.74₹367.21₹352.85
Total Assets₹797.01₹700.29₹587.42₹534.36
Current Liabilities₹106.22₹92.28₹72.15₹90.49
Net Current Asset₹393.72₹354.46₹295.07₹262.36
Non-Current Liabilities₹19.12₹15.18₹12.80₹10.99
Equity Capital₹671.67₹592.84₹502.47₹432.88
Total Equity & Liabilities₹797.01₹700.29₹587.42₹534.36

Income Statement · Standalone

Income Statement · Standalone — all values in INR Crore
ParticularsMar 2025Mar 2024Mar 2023Mar 2022
Revenue₹623.23₹580.55₹510.31₹472.08
Other Income₹22.48₹34.42₹22.48₹10.00
Total Revenue₹645.71₹614.97₹532.79₹482.08
Total Expenses₹536.52₹492.73₹432.34₹386.15
Profit Before Tax₹109.19₹122.24₹100.46₹95.93
Tax₹26.84₹28.94₹27.56₹26.57
Profit After Tax₹82.35₹93.30₹72.90₹69.35
EPS - Basic₹41.11₹46.58₹36.40₹34.63
EPS - Diluted₹41.11₹46.58₹36.40₹34.63

Cash Flow · Standalone

Cash Flow · Standalone — all values in INR Crore
ParticularsMar 2025Mar 2024Mar 2023Mar 2022
Profit before tax₹109.19₹122.24₹100.46₹95.93
Income before WC changes₹110.15₹105.49₹100.17₹97.42
Change in Assets-₹12.20-₹37.43-₹13.26-₹11.24
Change in Liabilities₹21.37₹21.32-₹18.15₹13.65
Change in WC₹9.17-₹16.12-₹31.40₹2.40
Cash flow from Operations₹93.02₹63.24₹39.16₹76.18
Cash flow from Investing-₹78.95-₹57.34-₹36.64-₹78.08
Cash flow from Financing-₹6.40-₹5.18-₹4.50-₹2.56
Total Cash Flow₹7.67₹0.73-₹1.99-₹4.46
Cash (Start of the year)₹5.31₹4.58₹6.57₹11.03
Cash (End of the year)₹12.97₹5.31₹4.58₹6.57

Balance Sheet · Standalone

Balance Sheet · Standalone — all values in INR Crore
ParticularsMar 2025Mar 2024Mar 2023Mar 2022
Non-Current Assets₹297.12₹262.56₹220.26₹181.56
Current Assets₹499.75₹437.59₹367.00₹352.56
Total Assets₹796.87₹700.15₹587.26₹534.11
Current Liabilities₹106.08₹92.14₹71.98₹90.24
Net Current Asset₹393.67₹345.45₹295.02₹262.31
Non-Current Liabilities₹19.12₹15.18₹12.80₹10.99
Equity Capital₹671.67₹592.84₹502.47₹432.88
Total Equity & Liabilities₹796.87₹700.15₹587.26₹534.11
* All values are in INR Crore
Qty
Bid
2
631.65
8
631.6
2
631.55
7
631.5
5
631.45
Ask
Qty
632.5
1
632.55
2
632.6
3
632.65
6
632.7
4
Bid Total: 24
Ask Total: 16
Buy orders: 60%
Sell orders: 40%
Bearish
2
Neutral
5
Bullish
1
Slightly Bearish
by SEBI experts
Expert Pick
EXPPICK
Stop-loss
Entry price
Target
Indicator
Value
Verdict
RSI (14)
56.07
Neutral
ATR (14)
14.86
Neutral
STOCH(9,6)
62.83
Neutral
STOCH RSI (14)
79.71
Bearish
ADX(9)
37.1
Bearish
UO(9)
44.64
Neutral
ROC(12)
1.85
Bullish
WillR(14)
-37.17
Neutral
Period
Simple value
Exponential vaue
5D
615.64
618
10D
615.02
615.78
20D
612.78
612.28
50D
605.55
611.05
100D
625.89
606.83
Volume trend — traded volume by day
7 Sep0L
4 Sep0L
3 Sep0L
2 Sep0L
1 Sep0L
31 Aug0L
Average0L

Technical indicators used here are for indicative purposes only. Kindly do not treat it as an investment or trading advice

Compare against other stocks
Lincoln Pharma Share Price
Lincoln Pharma
Pharmaceuticals
Add Stock
Add Another

Lincoln Pharma Share Price FAQs

Lincoln Pharma share price data is sourced from NSE/BSE and may be delayed. It is displayed for informational purposes only and does not constitute investment advice or a recommendation to buy or sell.

Trusted by 2 Crore+ Indians for their wealth-building needs. SEBI Registered Broker. SEBI Reg No. INZ000315837